nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—systemic lupus erythematosus	0.648	1	CbGaD
Maraviroc—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0187	0.146	CbGbCtD
Maraviroc—CYP3A4—Dapsone—systemic lupus erythematosus	0.0163	0.128	CbGbCtD
Maraviroc—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0142	0.111	CbGbCtD
Maraviroc—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0142	0.111	CbGbCtD
Maraviroc—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0121	0.0949	CbGbCtD
Maraviroc—CYP3A4—Prednisolone—systemic lupus erythematosus	0.012	0.0937	CbGbCtD
Maraviroc—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0114	0.0888	CbGbCtD
Maraviroc—CYP3A4—Prednisone—systemic lupus erythematosus	0.0113	0.0885	CbGbCtD
Maraviroc—CCR5—blood plasma—systemic lupus erythematosus	0.011	0.31	CbGeAlD
Maraviroc—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0107	0.0839	CbGbCtD
Maraviroc—CCR5—Early Phase of HIV Life Cycle—XRCC6—systemic lupus erythematosus	0.00793	0.157	CbGpPWpGaD
Maraviroc—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00706	0.0552	CbGbCtD
Maraviroc—CCR5—connective tissue—systemic lupus erythematosus	0.00584	0.165	CbGeAlD
Maraviroc—CCR5—Binding and entry of HIV virion—CD4—systemic lupus erythematosus	0.00489	0.0964	CbGpPWpGaD
Maraviroc—CCR5—lymphoid tissue—systemic lupus erythematosus	0.00427	0.121	CbGeAlD
Maraviroc—CCR5—lung—systemic lupus erythematosus	0.00352	0.0996	CbGeAlD
Maraviroc—CCR5—nervous system—systemic lupus erythematosus	0.00326	0.0922	CbGeAlD
Maraviroc—CCR5—central nervous system—systemic lupus erythematosus	0.00314	0.0888	CbGeAlD
Maraviroc—CYP3A4—urine—systemic lupus erythematosus	0.00212	0.0599	CbGeAlD
Maraviroc—CCR5—Early Phase of HIV Life Cycle—CD4—systemic lupus erythematosus	0.00179	0.0354	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD247—systemic lupus erythematosus	0.00167	0.033	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—STAT4—systemic lupus erythematosus	0.00147	0.0291	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL12—systemic lupus erythematosus	0.00138	0.0271	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL12B—systemic lupus erythematosus	0.00135	0.0266	CbGpPWpGaD
Maraviroc—CCR5—HIV Life Cycle—XRCC6—systemic lupus erythematosus	0.00129	0.0254	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD247—systemic lupus erythematosus	0.00121	0.0239	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—SH2B3—systemic lupus erythematosus	0.00115	0.0226	CbGpPWpGaD
Maraviroc—CYP3A4—blood plasma—systemic lupus erythematosus	0.00111	0.0313	CbGeAlD
Maraviroc—CCR5—TCR Signaling Pathway—IL17A—systemic lupus erythematosus	0.00105	0.0207	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL18—systemic lupus erythematosus	0.00099	0.0195	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD8A—systemic lupus erythematosus	0.000975	0.0192	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL4—systemic lupus erythematosus	0.000959	0.0189	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—FASLG—systemic lupus erythematosus	0.000917	0.0181	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—XRCC6—systemic lupus erythematosus	0.000889	0.0175	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL2RA—systemic lupus erythematosus	0.000879	0.0173	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—HLA-DRB1—systemic lupus erythematosus	0.000794	0.0157	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL2—systemic lupus erythematosus	0.000721	0.0142	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD8A—systemic lupus erythematosus	0.000705	0.0139	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.000649	0.0128	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—FAS—systemic lupus erythematosus	0.000639	0.0126	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—TYK2—systemic lupus erythematosus	0.000619	0.0122	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000602	0.0119	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—CD247—systemic lupus erythematosus	0.0006	0.0118	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IFNG—systemic lupus erythematosus	0.00058	0.0114	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—CD4—systemic lupus erythematosus	0.00056	0.0111	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000517	0.0102	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000516	0.0102	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL2—systemic lupus erythematosus	0.000515	0.0102	CbGpPWpGaD
Maraviroc—CYP3A4—kidney—systemic lupus erythematosus	0.000501	0.0142	CbGeAlD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.000437	0.00861	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD4—systemic lupus erythematosus	0.000405	0.00799	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000393	0.00775	CbGpPWpGaD
Maraviroc—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.00035	0.0069	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000347	0.00685	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000347	0.00684	CbGpPWpGaD
Maraviroc—CYP3A4—nervous system—systemic lupus erythematosus	0.000329	0.0093	CbGeAlD
Maraviroc—CYP3A4—central nervous system—systemic lupus erythematosus	0.000317	0.00895	CbGeAlD
Maraviroc—CCR5—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000304	0.006	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.000292	0.00577	CbGpPWpGaD
Maraviroc—CCR5—HIV Life Cycle—CD4—systemic lupus erythematosus	0.000291	0.00574	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—systemic lupus erythematosus	0.000291	0.00573	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000271	0.00535	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000264	0.00522	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000232	0.00459	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000222	0.00438	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—systemic lupus erythematosus	0.000219	0.00432	CbGpPWpGaD
Maraviroc—CCR5—Disease—XRCC6—systemic lupus erythematosus	0.000218	0.0043	CbGpPWpGaD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000209	0.00413	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000207	0.00409	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000204	0.00403	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000202	0.00398	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—CD4—systemic lupus erythematosus	0.000201	0.00397	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000182	0.00359	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—C3—systemic lupus erythematosus	0.000177	0.00349	CbGpPWpGaD
Maraviroc—CCR5—Disease—HIST2H2AC—systemic lupus erythematosus	0.000161	0.00317	CbGpPWpGaD
Maraviroc—CCR5—Disease—CSK—systemic lupus erythematosus	0.000156	0.00309	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—F2—systemic lupus erythematosus	0.000155	0.00307	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000149	0.00295	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD247—systemic lupus erythematosus	0.000147	0.0029	CbGpPWpGaD
Maraviroc—CCR5—Disease—NCF2—systemic lupus erythematosus	0.000143	0.00282	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000139	0.00275	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000139	0.00273	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000138	0.00272	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000136	0.00268	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000126	0.0025	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000123	0.00243	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000119	0.00235	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000119	0.00235	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000112	0.00222	CbGpPWpGaD
Maraviroc—CCR5—Disease—JUNB—systemic lupus erythematosus	0.000112	0.00222	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CSK—systemic lupus erythematosus	0.00011	0.00216	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000108	0.00213	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRL—systemic lupus erythematosus	0.000103	0.00204	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000101	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NCF2—systemic lupus erythematosus	0.0001	0.00198	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—C3—systemic lupus erythematosus	0.0001	0.00197	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LYN—systemic lupus erythematosus	9.96e-05	0.00196	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.81e-05	0.00194	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.77e-05	0.00193	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2RA—systemic lupus erythematosus	9.16e-05	0.00181	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C3—systemic lupus erythematosus	9.08e-05	0.00179	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—F2—systemic lupus erythematosus	8.78e-05	0.00173	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.34e-05	0.00165	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.3e-05	0.00164	CbGpPWpGaD
Maraviroc—CCR5—Disease—JAK1—systemic lupus erythematosus	8.28e-05	0.00163	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.01e-05	0.00158	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—F2—systemic lupus erythematosus	7.98e-05	0.00157	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JUNB—systemic lupus erythematosus	7.86e-05	0.00155	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.47e-05	0.00147	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRL—systemic lupus erythematosus	7.25e-05	0.00143	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.11e-05	0.0014	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.76e-05	0.00133	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.46e-05	0.00127	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD80—systemic lupus erythematosus	6.45e-05	0.00127	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	6.41e-05	0.00126	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.32e-05	0.00125	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.91e-05	0.00117	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JAK1—systemic lupus erythematosus	5.8e-05	0.00114	CbGpPWpGaD
Maraviroc—Renal failure—Methotrexate—systemic lupus erythematosus	5.71e-05	0.000412	CcSEcCtD
Maraviroc—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	5.69e-05	0.00041	CcSEcCtD
Maraviroc—Anorexia—Hydrocortisone—systemic lupus erythematosus	5.68e-05	0.00041	CcSEcCtD
Maraviroc—Stomatitis—Methotrexate—systemic lupus erythematosus	5.66e-05	0.000409	CcSEcCtD
Maraviroc—Angiopathy—Prednisone—systemic lupus erythematosus	5.66e-05	0.000409	CcSEcCtD
Maraviroc—Conjunctivitis—Methotrexate—systemic lupus erythematosus	5.65e-05	0.000408	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	5.65e-05	0.000408	CcSEcCtD
Maraviroc—Oedema—Triamcinolone—systemic lupus erythematosus	5.61e-05	0.000405	CcSEcCtD
Maraviroc—Syncope—Dexamethasone—systemic lupus erythematosus	5.6e-05	0.000404	CcSEcCtD
Maraviroc—Syncope—Betamethasone—systemic lupus erythematosus	5.6e-05	0.000404	CcSEcCtD
Maraviroc—Pain—Mycophenolate mofetil—systemic lupus erythematosus	5.59e-05	0.000404	CcSEcCtD
Maraviroc—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	5.59e-05	0.000404	CcSEcCtD
Maraviroc—Infection—Triamcinolone—systemic lupus erythematosus	5.58e-05	0.000402	CcSEcCtD
Maraviroc—Infection—Methylprednisolone—systemic lupus erythematosus	5.56e-05	0.000402	CcSEcCtD
Maraviroc—Vomiting—Leflunomide—systemic lupus erythematosus	5.53e-05	0.000399	CcSEcCtD
Maraviroc—Shock—Triamcinolone—systemic lupus erythematosus	5.52e-05	0.000399	CcSEcCtD
Maraviroc—Insomnia—Prednisolone—systemic lupus erythematosus	5.52e-05	0.000398	CcSEcCtD
Maraviroc—Alopecia—Prednisone—systemic lupus erythematosus	5.52e-05	0.000398	CcSEcCtD
Maraviroc—Shock—Methylprednisolone—systemic lupus erythematosus	5.51e-05	0.000398	CcSEcCtD
Maraviroc—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	5.5e-05	0.000397	CcSEcCtD
Maraviroc—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	5.49e-05	0.000396	CcSEcCtD
Maraviroc—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	5.48e-05	0.000396	CcSEcCtD
Maraviroc—Loss of consciousness—Betamethasone—systemic lupus erythematosus	5.48e-05	0.000396	CcSEcCtD
Maraviroc—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	5.48e-05	0.000396	CcSEcCtD
Maraviroc—Paraesthesia—Prednisolone—systemic lupus erythematosus	5.48e-05	0.000396	CcSEcCtD
Maraviroc—Rash—Leflunomide—systemic lupus erythematosus	5.48e-05	0.000395	CcSEcCtD
Maraviroc—Dermatitis—Leflunomide—systemic lupus erythematosus	5.47e-05	0.000395	CcSEcCtD
Maraviroc—Mental disorder—Prednisone—systemic lupus erythematosus	5.47e-05	0.000395	CcSEcCtD
Maraviroc—Nausea—Azathioprine—systemic lupus erythematosus	5.47e-05	0.000394	CcSEcCtD
Maraviroc—CCR5—Disease—TYK2—systemic lupus erythematosus	5.45e-05	0.00107	CbGpPWpGaD
Maraviroc—Headache—Leflunomide—systemic lupus erythematosus	5.44e-05	0.000393	CcSEcCtD
Maraviroc—Skin disorder—Methylprednisolone—systemic lupus erythematosus	5.44e-05	0.000393	CcSEcCtD
Maraviroc—Erythema—Prednisone—systemic lupus erythematosus	5.43e-05	0.000392	CcSEcCtD
Maraviroc—Malnutrition—Prednisone—systemic lupus erythematosus	5.43e-05	0.000392	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	5.43e-05	0.000392	CcSEcCtD
Maraviroc—Agranulocytosis—Methotrexate—systemic lupus erythematosus	5.42e-05	0.000391	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.41e-05	0.00107	CbGpPWpGaD
Maraviroc—Convulsion—Betamethasone—systemic lupus erythematosus	5.41e-05	0.00039	CcSEcCtD
Maraviroc—Convulsion—Dexamethasone—systemic lupus erythematosus	5.41e-05	0.00039	CcSEcCtD
Maraviroc—Insomnia—Hydrocortisone—systemic lupus erythematosus	5.39e-05	0.000389	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL2—systemic lupus erythematosus	5.37e-05	0.00106	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3—systemic lupus erythematosus	5.37e-05	0.00106	CbGpPWpGaD
Maraviroc—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	5.35e-05	0.000386	CcSEcCtD
Maraviroc—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.35e-05	0.000386	CcSEcCtD
Maraviroc—CCR5—Disease—NOS3—systemic lupus erythematosus	5.34e-05	0.00105	CbGpPWpGaD
Maraviroc—Myalgia—Dexamethasone—systemic lupus erythematosus	5.31e-05	0.000383	CcSEcCtD
Maraviroc—Myalgia—Betamethasone—systemic lupus erythematosus	5.31e-05	0.000383	CcSEcCtD
Maraviroc—Abdominal pain—Cyclosporine—systemic lupus erythematosus	5.3e-05	0.000383	CcSEcCtD
Maraviroc—Body temperature increased—Cyclosporine—systemic lupus erythematosus	5.3e-05	0.000383	CcSEcCtD
Maraviroc—Anxiety—Dexamethasone—systemic lupus erythematosus	5.29e-05	0.000382	CcSEcCtD
Maraviroc—Anxiety—Betamethasone—systemic lupus erythematosus	5.29e-05	0.000382	CcSEcCtD
Maraviroc—Discomfort—Dexamethasone—systemic lupus erythematosus	5.25e-05	0.000379	CcSEcCtD
Maraviroc—Discomfort—Betamethasone—systemic lupus erythematosus	5.25e-05	0.000379	CcSEcCtD
Maraviroc—Pain—Prednisolone—systemic lupus erythematosus	5.22e-05	0.000377	CcSEcCtD
Maraviroc—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	5.18e-05	0.000374	CcSEcCtD
Maraviroc—Pharyngitis—Methotrexate—systemic lupus erythematosus	5.18e-05	0.000374	CcSEcCtD
Maraviroc—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.17e-05	0.000373	CcSEcCtD
Maraviroc—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.17e-05	0.000373	CcSEcCtD
Maraviroc—Nausea—Leflunomide—systemic lupus erythematosus	5.16e-05	0.000373	CcSEcCtD
Maraviroc—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	5.15e-05	0.000372	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	5.15e-05	0.000371	CcSEcCtD
Maraviroc—Fatigue—Hydrocortisone—systemic lupus erythematosus	5.14e-05	0.000371	CcSEcCtD
Maraviroc—Urethral disorder—Methotrexate—systemic lupus erythematosus	5.11e-05	0.000369	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.11e-05	0.000369	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5.1e-05	0.000368	CcSEcCtD
Maraviroc—Pain—Hydrocortisone—systemic lupus erythematosus	5.1e-05	0.000368	CcSEcCtD
Maraviroc—Oedema—Dexamethasone—systemic lupus erythematosus	5.09e-05	0.000368	CcSEcCtD
Maraviroc—Oedema—Betamethasone—systemic lupus erythematosus	5.09e-05	0.000368	CcSEcCtD
Maraviroc—Insomnia—Triamcinolone—systemic lupus erythematosus	5.08e-05	0.000366	CcSEcCtD
Maraviroc—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.06e-05	0.000366	CcSEcCtD
Maraviroc—Infection—Betamethasone—systemic lupus erythematosus	5.06e-05	0.000365	CcSEcCtD
Maraviroc—Infection—Dexamethasone—systemic lupus erythematosus	5.06e-05	0.000365	CcSEcCtD
Maraviroc—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.04e-05	0.000364	CcSEcCtD
Maraviroc—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.03e-05	0.000363	CcSEcCtD
Maraviroc—Anaemia—Prednisone—systemic lupus erythematosus	5.02e-05	0.000362	CcSEcCtD
Maraviroc—Shock—Dexamethasone—systemic lupus erythematosus	5.01e-05	0.000362	CcSEcCtD
Maraviroc—Shock—Betamethasone—systemic lupus erythematosus	5.01e-05	0.000362	CcSEcCtD
Maraviroc—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.99e-05	0.00036	CcSEcCtD
Maraviroc—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.99e-05	0.00036	CcSEcCtD
Maraviroc—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.94e-05	0.000357	CcSEcCtD
Maraviroc—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.93e-05	0.000356	CcSEcCtD
Maraviroc—CCR5—Disease—CD4—systemic lupus erythematosus	4.92e-05	0.000972	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—systemic lupus erythematosus	4.89e-05	0.000965	CbGpPWpGaD
Maraviroc—Eye disorder—Methotrexate—systemic lupus erythematosus	4.88e-05	0.000352	CcSEcCtD
Maraviroc—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.87e-05	0.000352	CcSEcCtD
Maraviroc—Syncope—Prednisone—systemic lupus erythematosus	4.87e-05	0.000352	CcSEcCtD
Maraviroc—Anorexia—Dexamethasone—systemic lupus erythematosus	4.85e-05	0.00035	CcSEcCtD
Maraviroc—Anorexia—Betamethasone—systemic lupus erythematosus	4.85e-05	0.00035	CcSEcCtD
Maraviroc—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.84e-05	0.000349	CcSEcCtD
Maraviroc—Fatigue—Triamcinolone—systemic lupus erythematosus	4.84e-05	0.000349	CcSEcCtD
Maraviroc—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.83e-05	0.000348	CcSEcCtD
Maraviroc—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.82e-05	0.000348	CcSEcCtD
Maraviroc—Asthenia—Cyclosporine—systemic lupus erythematosus	4.81e-05	0.000347	CcSEcCtD
Maraviroc—Pain—Triamcinolone—systemic lupus erythematosus	4.8e-05	0.000346	CcSEcCtD
Maraviroc—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.78e-05	0.000345	CcSEcCtD
Maraviroc—Pruritus—Cyclosporine—systemic lupus erythematosus	4.74e-05	0.000342	CcSEcCtD
Maraviroc—Angiopathy—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000342	CcSEcCtD
Maraviroc—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.71e-05	0.00034	CcSEcCtD
Maraviroc—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.71e-05	0.00034	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—F2—systemic lupus erythematosus	4.71e-05	0.00093	CbGpPWpGaD
Maraviroc—Convulsion—Prednisone—systemic lupus erythematosus	4.71e-05	0.00034	CcSEcCtD
Maraviroc—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000339	CcSEcCtD
Maraviroc—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.69e-05	0.000339	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.64e-05	0.000335	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.64e-05	0.000335	CcSEcCtD
Maraviroc—CCR5—Disease—CDKN1B—systemic lupus erythematosus	4.63e-05	0.000914	CbGpPWpGaD
Maraviroc—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.63e-05	0.000334	CcSEcCtD
Maraviroc—Myalgia—Prednisone—systemic lupus erythematosus	4.63e-05	0.000334	CcSEcCtD
Maraviroc—Anxiety—Prednisone—systemic lupus erythematosus	4.61e-05	0.000333	CcSEcCtD
Maraviroc—Alopecia—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000333	CcSEcCtD
Maraviroc—Insomnia—Dexamethasone—systemic lupus erythematosus	4.61e-05	0.000332	CcSEcCtD
Maraviroc—Insomnia—Betamethasone—systemic lupus erythematosus	4.61e-05	0.000332	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.59e-05	0.000332	CcSEcCtD
Maraviroc—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.59e-05	0.000331	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.58e-05	0.00033	CcSEcCtD
Maraviroc—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.57e-05	0.00033	CcSEcCtD
Maraviroc—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.57e-05	0.00033	CcSEcCtD
Maraviroc—Discomfort—Prednisone—systemic lupus erythematosus	4.57e-05	0.00033	CcSEcCtD
Maraviroc—Mental disorder—Methotrexate—systemic lupus erythematosus	4.57e-05	0.00033	CcSEcCtD
Maraviroc—Erythema—Methotrexate—systemic lupus erythematosus	4.54e-05	0.000328	CcSEcCtD
Maraviroc—Malnutrition—Methotrexate—systemic lupus erythematosus	4.54e-05	0.000328	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CD80—systemic lupus erythematosus	4.52e-05	0.000891	CbGpPWpGaD
Maraviroc—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.5e-05	0.000325	CcSEcCtD
Maraviroc—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.48e-05	0.000323	CcSEcCtD
Maraviroc—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.44e-05	0.00032	CcSEcCtD
Maraviroc—Dizziness—Cyclosporine—systemic lupus erythematosus	4.43e-05	0.00032	CcSEcCtD
Maraviroc—Oedema—Prednisone—systemic lupus erythematosus	4.43e-05	0.00032	CcSEcCtD
Maraviroc—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.43e-05	0.00032	CcSEcCtD
Maraviroc—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.43e-05	0.00032	CcSEcCtD
Maraviroc—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.43e-05	0.00032	CcSEcCtD
Maraviroc—Infection—Prednisone—systemic lupus erythematosus	4.41e-05	0.000318	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.4e-05	0.000317	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.4e-05	0.000317	CcSEcCtD
Maraviroc—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.39e-05	0.000317	CcSEcCtD
Maraviroc—Fatigue—Dexamethasone—systemic lupus erythematosus	4.39e-05	0.000317	CcSEcCtD
Maraviroc—Fatigue—Betamethasone—systemic lupus erythematosus	4.39e-05	0.000317	CcSEcCtD
Maraviroc—Shock—Prednisone—systemic lupus erythematosus	4.36e-05	0.000315	CcSEcCtD
Maraviroc—Pain—Betamethasone—systemic lupus erythematosus	4.35e-05	0.000314	CcSEcCtD
Maraviroc—Pain—Dexamethasone—systemic lupus erythematosus	4.35e-05	0.000314	CcSEcCtD
Maraviroc—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.35e-05	0.000314	CcSEcCtD
Maraviroc—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.33e-05	0.000312	CcSEcCtD
Maraviroc—Skin disorder—Prednisone—systemic lupus erythematosus	4.31e-05	0.000311	CcSEcCtD
Maraviroc—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.28e-05	0.000309	CcSEcCtD
Maraviroc—CCR5—Disease—CDKN1A—systemic lupus erythematosus	4.27e-05	0.000843	CbGpPWpGaD
Maraviroc—Vomiting—Cyclosporine—systemic lupus erythematosus	4.26e-05	0.000308	CcSEcCtD
Maraviroc—Rash—Cyclosporine—systemic lupus erythematosus	4.23e-05	0.000305	CcSEcCtD
Maraviroc—Anorexia—Prednisone—systemic lupus erythematosus	4.23e-05	0.000305	CcSEcCtD
Maraviroc—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.22e-05	0.000305	CcSEcCtD
Maraviroc—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.22e-05	0.000304	CcSEcCtD
Maraviroc—Headache—Cyclosporine—systemic lupus erythematosus	4.2e-05	0.000303	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCL2—systemic lupus erythematosus	4.2e-05	0.000829	CbGpPWpGaD
Maraviroc—Anaemia—Methotrexate—systemic lupus erythematosus	4.2e-05	0.000303	CcSEcCtD
Maraviroc—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.16e-05	0.000301	CcSEcCtD
Maraviroc—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.16e-05	0.000301	CcSEcCtD
Maraviroc—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.16e-05	0.0003	CcSEcCtD
Maraviroc—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.13e-05	0.000298	CcSEcCtD
Maraviroc—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.13e-05	0.000298	CcSEcCtD
Maraviroc—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.13e-05	0.000298	CcSEcCtD
Maraviroc—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.12e-05	0.000297	CcSEcCtD
Maraviroc—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.1e-05	0.000296	CcSEcCtD
Maraviroc—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.08e-05	0.000294	CcSEcCtD
Maraviroc—CCR5—Disease—EP300—systemic lupus erythematosus	4.07e-05	0.000802	CbGpPWpGaD
Maraviroc—Leukopenia—Methotrexate—systemic lupus erythematosus	4.06e-05	0.000293	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.04e-05	0.000292	CcSEcCtD
Maraviroc—Dizziness—Prednisolone—systemic lupus erythematosus	4.04e-05	0.000291	CcSEcCtD
Maraviroc—Asthenia—Triamcinolone—systemic lupus erythematosus	4.03e-05	0.000291	CcSEcCtD
Maraviroc—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.03e-05	0.000291	CcSEcCtD
Maraviroc—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.000291	CcSEcCtD
Maraviroc—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.000291	CcSEcCtD
Maraviroc—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.03e-05	0.000291	CcSEcCtD
Maraviroc—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.02e-05	0.00029	CcSEcCtD
Maraviroc—Insomnia—Prednisone—systemic lupus erythematosus	4.01e-05	0.000289	CcSEcCtD
Maraviroc—Nausea—Cyclosporine—systemic lupus erythematosus	3.98e-05	0.000288	CcSEcCtD
Maraviroc—Paraesthesia—Prednisone—systemic lupus erythematosus	3.98e-05	0.000287	CcSEcCtD
Maraviroc—Pruritus—Triamcinolone—systemic lupus erythematosus	3.97e-05	0.000287	CcSEcCtD
Maraviroc—Cough—Methotrexate—systemic lupus erythematosus	3.96e-05	0.000286	CcSEcCtD
Maraviroc—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.96e-05	0.000286	CcSEcCtD
Maraviroc—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.94e-05	0.000284	CcSEcCtD
Maraviroc—Convulsion—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000284	CcSEcCtD
Maraviroc—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.89e-05	0.00028	CcSEcCtD
Maraviroc—Myalgia—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000279	CcSEcCtD
Maraviroc—Decreased appetite—Prednisone—systemic lupus erythematosus	3.86e-05	0.000278	CcSEcCtD
Maraviroc—Rash—Prednisolone—systemic lupus erythematosus	3.85e-05	0.000278	CcSEcCtD
Maraviroc—Dermatitis—Prednisolone—systemic lupus erythematosus	3.84e-05	0.000277	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000277	CcSEcCtD
Maraviroc—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.83e-05	0.000277	CcSEcCtD
Maraviroc—Fatigue—Prednisone—systemic lupus erythematosus	3.82e-05	0.000276	CcSEcCtD
Maraviroc—Headache—Prednisolone—systemic lupus erythematosus	3.82e-05	0.000276	CcSEcCtD
Maraviroc—Discomfort—Methotrexate—systemic lupus erythematosus	3.82e-05	0.000276	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TYK2—systemic lupus erythematosus	3.81e-05	0.000752	CbGpPWpGaD
Maraviroc—Constipation—Prednisone—systemic lupus erythematosus	3.79e-05	0.000274	CcSEcCtD
Maraviroc—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.79e-05	0.000274	CcSEcCtD
Maraviroc—Rash—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000271	CcSEcCtD
Maraviroc—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.75e-05	0.000271	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NOS3—systemic lupus erythematosus	3.74e-05	0.000739	CbGpPWpGaD
Maraviroc—Headache—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.000269	CcSEcCtD
Maraviroc—Dizziness—Triamcinolone—systemic lupus erythematosus	3.71e-05	0.000268	CcSEcCtD
Maraviroc—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.7e-05	0.000267	CcSEcCtD
Maraviroc—Infection—Methotrexate—systemic lupus erythematosus	3.68e-05	0.000266	CcSEcCtD
Maraviroc—Asthenia—Dexamethasone—systemic lupus erythematosus	3.65e-05	0.000264	CcSEcCtD
Maraviroc—Asthenia—Betamethasone—systemic lupus erythematosus	3.65e-05	0.000264	CcSEcCtD
Maraviroc—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.63e-05	0.000262	CcSEcCtD
Maraviroc—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.63e-05	0.000262	CcSEcCtD
Maraviroc—Nausea—Prednisolone—systemic lupus erythematosus	3.62e-05	0.000262	CcSEcCtD
Maraviroc—Pruritus—Betamethasone—systemic lupus erythematosus	3.6e-05	0.00026	CcSEcCtD
Maraviroc—Pruritus—Dexamethasone—systemic lupus erythematosus	3.6e-05	0.00026	CcSEcCtD
Maraviroc—Skin disorder—Methotrexate—systemic lupus erythematosus	3.6e-05	0.00026	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.59e-05	0.000709	CbGpPWpGaD
Maraviroc—Vomiting—Triamcinolone—systemic lupus erythematosus	3.57e-05	0.000258	CcSEcCtD
Maraviroc—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.56e-05	0.000257	CcSEcCtD
Maraviroc—Nausea—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.000256	CcSEcCtD
Maraviroc—Rash—Triamcinolone—systemic lupus erythematosus	3.54e-05	0.000255	CcSEcCtD
Maraviroc—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.54e-05	0.000255	CcSEcCtD
Maraviroc—CCR5—Disease—TGFB1—systemic lupus erythematosus	3.53e-05	0.000697	CbGpPWpGaD
Maraviroc—Anorexia—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000255	CcSEcCtD
Maraviroc—Rash—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000255	CcSEcCtD
Maraviroc—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000255	CcSEcCtD
Maraviroc—Headache—Triamcinolone—systemic lupus erythematosus	3.52e-05	0.000254	CcSEcCtD
Maraviroc—Headache—Methylprednisolone—systemic lupus erythematosus	3.51e-05	0.000253	CcSEcCtD
Maraviroc—Abdominal pain—Prednisone—systemic lupus erythematosus	3.51e-05	0.000253	CcSEcCtD
Maraviroc—Body temperature increased—Prednisone—systemic lupus erythematosus	3.51e-05	0.000253	CcSEcCtD
Maraviroc—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.48e-05	0.000251	CcSEcCtD
Maraviroc—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.48e-05	0.000251	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.38e-05	0.000244	CcSEcCtD
Maraviroc—Dizziness—Betamethasone—systemic lupus erythematosus	3.37e-05	0.000243	CcSEcCtD
Maraviroc—Dizziness—Dexamethasone—systemic lupus erythematosus	3.37e-05	0.000243	CcSEcCtD
Maraviroc—Insomnia—Methotrexate—systemic lupus erythematosus	3.35e-05	0.000242	CcSEcCtD
Maraviroc—Nausea—Triamcinolone—systemic lupus erythematosus	3.33e-05	0.000241	CcSEcCtD
Maraviroc—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.33e-05	0.00024	CcSEcCtD
Maraviroc—Nausea—Methylprednisolone—systemic lupus erythematosus	3.33e-05	0.00024	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.27e-05	0.000236	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.24e-05	0.00064	CbGpPWpGaD
Maraviroc—Vomiting—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.000234	CcSEcCtD
Maraviroc—Vomiting—Betamethasone—systemic lupus erythematosus	3.24e-05	0.000234	CcSEcCtD
Maraviroc—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.22e-05	0.000233	CcSEcCtD
Maraviroc—Rash—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000232	CcSEcCtD
Maraviroc—Rash—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000232	CcSEcCtD
Maraviroc—Dermatitis—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000232	CcSEcCtD
Maraviroc—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000232	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000231	CcSEcCtD
Maraviroc—Fatigue—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000231	CcSEcCtD
Maraviroc—Headache—Betamethasone—systemic lupus erythematosus	3.19e-05	0.00023	CcSEcCtD
Maraviroc—Headache—Dexamethasone—systemic lupus erythematosus	3.19e-05	0.00023	CcSEcCtD
Maraviroc—Asthenia—Prednisone—systemic lupus erythematosus	3.18e-05	0.00023	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2—systemic lupus erythematosus	3.17e-05	0.000626	CbGpPWpGaD
Maraviroc—Pain—Methotrexate—systemic lupus erythematosus	3.17e-05	0.000229	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6—systemic lupus erythematosus	3.16e-05	0.000623	CbGpPWpGaD
Maraviroc—Pruritus—Prednisone—systemic lupus erythematosus	3.14e-05	0.000226	CcSEcCtD
Maraviroc—Diarrhoea—Prednisone—systemic lupus erythematosus	3.03e-05	0.000219	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.03e-05	0.000219	CcSEcCtD
Maraviroc—Nausea—Betamethasone—systemic lupus erythematosus	3.02e-05	0.000218	CcSEcCtD
Maraviroc—Nausea—Dexamethasone—systemic lupus erythematosus	3.02e-05	0.000218	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MMP9—systemic lupus erythematosus	3e-05	0.000593	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.99e-05	0.00059	CbGpPWpGaD
Maraviroc—Dizziness—Prednisone—systemic lupus erythematosus	2.93e-05	0.000212	CcSEcCtD
Maraviroc—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.93e-05	0.000211	CcSEcCtD
Maraviroc—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.93e-05	0.000211	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—EP300—systemic lupus erythematosus	2.85e-05	0.000562	CbGpPWpGaD
Maraviroc—Vomiting—Prednisone—systemic lupus erythematosus	2.82e-05	0.000204	CcSEcCtD
Maraviroc—Rash—Prednisone—systemic lupus erythematosus	2.8e-05	0.000202	CcSEcCtD
Maraviroc—Dermatitis—Prednisone—systemic lupus erythematosus	2.79e-05	0.000202	CcSEcCtD
Maraviroc—Headache—Prednisone—systemic lupus erythematosus	2.78e-05	0.000201	CcSEcCtD
Maraviroc—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000197	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.7e-05	0.000532	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—systemic lupus erythematosus	2.66e-05	0.000526	CbGpPWpGaD
Maraviroc—Asthenia—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000192	CcSEcCtD
Maraviroc—Nausea—Prednisone—systemic lupus erythematosus	2.63e-05	0.00019	CcSEcCtD
Maraviroc—Pruritus—Methotrexate—systemic lupus erythematosus	2.62e-05	0.000189	CcSEcCtD
Maraviroc—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.54e-05	0.000183	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.47e-05	0.000488	CbGpPWpGaD
Maraviroc—Dizziness—Methotrexate—systemic lupus erythematosus	2.45e-05	0.000177	CcSEcCtD
Maraviroc—Vomiting—Methotrexate—systemic lupus erythematosus	2.36e-05	0.00017	CcSEcCtD
Maraviroc—Rash—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000169	CcSEcCtD
Maraviroc—Dermatitis—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000169	CcSEcCtD
Maraviroc—Headache—Methotrexate—systemic lupus erythematosus	2.32e-05	0.000168	CcSEcCtD
Maraviroc—Nausea—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000159	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL6—systemic lupus erythematosus	1.86e-05	0.000368	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.1e-05	0.000216	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	6.14e-06	0.000121	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.88e-06	7.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.49e-06	6.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.34e-06	6.58e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.05e-06	6.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.54e-06	5.01e-05	CbGpPWpGaD
